SRA's number for the day: 51
This article was originally published in SRA
The US Food and Drug Administration has till now received 51 requests for initial meetings to discuss biosimilar development programs involving 12 different reference biological products1.
You may also be interested in...
An EU pilot project will assess whether there is sufficient demand from companies to obtain simultaneous scientific advice from EU national competent authorities.
An ambitious action plan drawn by an EU task force, if implemented on a priority basis by the European Commission, could increase the EU’s capacity to advise on, assess and analyze big data.
Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.